N-(2-arylethyl) benzylamines as antagonists of 5-HT6 receptor

Disclosed are compounds of a general formula (I) and (II), their use in the manufacture of medicaments for the treatment of 5-HT6 receptor mediated diseases and pharmaceutical compositions containing them. Opísané sú zlúčeniny všeobecného vzorca (I) a (II), ich použitie na prípravu liečiv na liečeni...

Full description

Saved in:
Bibliographic Details
Main Authors GIETHLEN BRUNO, GILLIG JAMES RONALD, MCCOWAN JEFFERSON RAY, FISHER MATTHEW JOSEPH, COHEN MICHAEL PHILIP, CHEN ZHAOGEN, MILLER SHAWN CHRISTOPHER, SCHAUS JOHN MEHNERT
Format Patent
LanguageEnglish
Slovak
Published 07.10.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed are compounds of a general formula (I) and (II), their use in the manufacture of medicaments for the treatment of 5-HT6 receptor mediated diseases and pharmaceutical compositions containing them. Opísané sú zlúčeniny všeobecného vzorca (I) a (II), ich použitie na prípravu liečiv na liečenie ochorení súvisiacich s receptormi 5-HT6 a farmaceutické kompozície s ich obsahom.
AbstractList Disclosed are compounds of a general formula (I) and (II), their use in the manufacture of medicaments for the treatment of 5-HT6 receptor mediated diseases and pharmaceutical compositions containing them. Opísané sú zlúčeniny všeobecného vzorca (I) a (II), ich použitie na prípravu liečiv na liečenie ochorení súvisiacich s receptormi 5-HT6 a farmaceutické kompozície s ich obsahom.
Author CHEN ZHAOGEN
COHEN MICHAEL PHILIP
SCHAUS JOHN MEHNERT
MILLER SHAWN CHRISTOPHER
GILLIG JAMES RONALD
MCCOWAN JEFFERSON RAY
GIETHLEN BRUNO
FISHER MATTHEW JOSEPH
Author_xml – fullname: GIETHLEN BRUNO
– fullname: GILLIG JAMES RONALD
– fullname: MCCOWAN JEFFERSON RAY
– fullname: FISHER MATTHEW JOSEPH
– fullname: COHEN MICHAEL PHILIP
– fullname: CHEN ZHAOGEN
– fullname: MILLER SHAWN CHRISTOPHER
– fullname: SCHAUS JOHN MEHNERT
BookMark eNrjYmDJy89L5WSw9dPVMNJNLKrMSS3JqMzRVEhKzauqzEnMzcxLLVZIBKK8ksT0_LzM4pJihfw0BVNdjxAzhaLU5NSCkvwiHgbWtMSc4lReKM3NoODmGuLsoZtakB-fWlyQmJyal1oSH-xtZGFuYmbs5GRmTIQSADwvMI4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate N-(2-aryletyl)benzylamíny ako antagonisty receptora 5-HT6
ExternalDocumentID SK287463BB6
GroupedDBID EVB
ID FETCH-epo_espacenet_SK287463BB63
IEDL.DBID EVB
IngestDate Fri Jul 19 12:56:31 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Slovak
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SK287463BB63
Notes Application Number: SK20030001205
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101007&DB=EPODOC&CC=SK&NR=287463B6
ParticipantIDs epo_espacenet_SK287463BB6
PublicationCentury 2000
PublicationDate 20101007
PublicationDateYYYYMMDD 2010-10-07
PublicationDate_xml – month: 10
  year: 2010
  text: 20101007
  day: 07
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies ELI LILLY AND COMPANY
RelatedCompanies_xml – name: ELI LILLY AND COMPANY
Score 2.7845676
Snippet Disclosed are compounds of a general formula (I) and (II), their use in the manufacture of medicaments for the treatment of 5-HT6 receptor mediated diseases...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title N-(2-arylethyl) benzylamines as antagonists of 5-HT6 receptor
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101007&DB=EPODOC&locale=&CC=SK&NR=287463B6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp7L5RR6k6ENwW7p0eyhCvyiOfeCq7G00bcoE6cZakfrXeymd-qKQh5DAcbnkcrlc7heAG5ZERlugWxIlUlBdRAYVcWdAedcQzIgjJnWVjTwac_9Zf5z35jVYbnNhSpzQjxIcETUqQn3Py_16_XOJ5ZRvK7N78YpNqwcvMB2t8o5xfaHN0xzLdKcTZ2Jrtm3Ohtr4yVSw7pxZfAd28RBtKF1wXyyVk7L-bVC8I9ibIq00P4aaTBtwYG__XWvA_qgKd2O10rzsBMwxve3ScFOgnJfF2x0RMv0scDrVs3USYklVfEnh4GZklZAe9QNOcDuTa_SqT4F4bmD7FPlYfA95MRtWDFucnUE9XaWyCWSQ9BMpZYe3w74es1ChB7Eeekyh6HSjmLWg9SeZ83_6LuCwDIqruLhxCfV88y6v0Nbm4roU0xcpOYPo
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTsX5mQcp-hBcly7dHorQdqO6rRuuyt5G06ZMkG5sFZl_vZfSqS8KeQgJHJdLLpfL5X4BuGZJZNYFuiVRIgU1RGRSEettyhumYGYcMWmobOSBz71n43HSnJRgtsmFyXFCP3JwRNSoCPU9y_frxc8llpu_rVzdiVdsmt93A8vVCu8Y1xfaPM21rc5o6A4dzXGscU_znywF686ZzbdgGw_YptKFzoutclIWvw1Kdx92RkgrzQ6gJNMqVJzNv2tV2B0U4W6sFpq3OgTLpzcNGi7XKOfZ-u2WCJl-rnE61bN1EmJJVXxJ4eCuyDwhTeoFnOB2JhfoVR8B6XYCx6PIx_R7yNNxr2DY5uwYyuk8lSdA2kkrkVLqvB62jJiFCj2INdFjCoXeiGJWg9qfZE7_6buCihcM-tP-g987g708QK5i5OY5lLPlu7xAu5uJy1xkX4Schts
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=N-%282-arylethyl%29+benzylamines+as+antagonists+of+5-HT6+receptor&rft.inventor=GIETHLEN+BRUNO&rft.inventor=GILLIG+JAMES+RONALD&rft.inventor=MCCOWAN+JEFFERSON+RAY&rft.inventor=FISHER+MATTHEW+JOSEPH&rft.inventor=COHEN+MICHAEL+PHILIP&rft.inventor=CHEN+ZHAOGEN&rft.inventor=MILLER+SHAWN+CHRISTOPHER&rft.inventor=SCHAUS+JOHN+MEHNERT&rft.date=2010-10-07&rft.externalDBID=B6&rft.externalDocID=SK287463BB6